MARIANA COOPER: Open Payments
NPI 1841349297 · MEDFORD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,923 in 84 payments from 13 companies in 2025. Trend: 2023 $1,347 · 2024 $1,754 · 2025 $1,923
Food & beverage: $1,823Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $424 |
| REVANCE THERAPEUTICS, INC. | 6 | $373 |
| Lilly USA, LLC | 11 | $267 |
| UCB, Inc. | 8 | $236 |
| ABBVIE INC. | 20 | $205 |
| GENZYME CORPORATION | 9 | $140 |
| LEO Pharma Inc. | 1 | $114 |
| Amgen Inc. | 3 | $49 |
| Arcutis Biotherapeutics, Inc. | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
Products named: TREMFYA, DAXXIFY, Bimzelx, EBGLYSS, DUPIXENT, SKYRIZI, ANZUPGO, TALTZ.
Industry payments across OR — which companies pay providers there.
